Immune agonist, checkpoint inhibitor combo shows good tolerabilityJune 15, 2016Genitourinary CancerBreast CancerLung CancerMelanomaRenal Cell Carcinoma
Daratumumab plus len-dex stalls myeloma progression in POLLUX trialJune 15, 2016Lymphoma & Plasma Cell Disorders
Blinatumomab doubles survival in relapsed Ph-negative ALLJune 15, 2016Leukemia, Myelodysplasia, Transplantation
Neoadjuvant chemo for advanced ovarian cancer opens ‘window of opportunity’ for immunotherapiesJune 15, 2016Gynecologic CancerImmuno-oncology
Follicular lymphoma with histologic transformation may merit ASCTJune 14, 2016Lymphoma & Plasma Cell DisordersFollicular Lymphoma
Tyrosine kinase inhibitors may boost cardiac risk in chronic myeloid leukemiaJune 13, 2016Leukemia, Myelodysplasia, Transplantation
Atezolizumab has good showing as first-line therapy in urothelial cancerJune 13, 2016Genitourinary Cancer
‘Meticulous’ surgical procedure best defense against rectal cancer recurrenceJune 13, 2016GastroenterologyGastrointestinal Cancer
Tissue flap reconstruction associated with higher costs, postop complication riskJune 13, 2016GastroenterologyGastrointestinal Cancer
